Principal Research Scientist I, Immuno-Pharmacology

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

We are seeking an accomplished Principal Scientist I to lead innovative peptide therapeutic programs in AbbVie’s Immunology Discovery organization in our Immuno-Pharmacology and Peptide Discovery department. The candidate will provide scientific and people leadership for peptide projects spanning early-stage discovery efforts as well as IND-enabling development programs. In addition, this role will spearhead platform initiatives to advance AbbVie���s peptide capabilities across immunology, ensuring that cutting-edge peptide technologies are leveraged to address critical needs in autoimmune and inflammatory diseases. Working within a cross-functional, matrixed team environment, the Principal Scientist I will drive robust data generation and clear communication to meet key program milestones. The successful candidate will collaborate extensively with internal and external partners, representing their programs in internal governance reviews and at external scientific forums. Through strong leadership and deep expertise in immunology and peptide science, this individual will champion AbbVie’s patient-focused R&D mission by translating breakthrough peptide research into novel immunology therapies for patients.

Responsibilities:

• Principal Investigator Leadership: Act as a principal investigator, spearheading peptide biology and immunology research programs while generating novel therapeutic ideas and guiding the scientific strategy to advance AbbVie’s peptide therapeutic platform.
• Drive Program Execution: Independently lead the scientific execution of one or more peptide therapeutic programs, taking accountability for experimental design, data integrity, and